Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study

Daniel R. Morales(University of Dundee), Marc A. Suchard(University of California, Los Angeles), Michael E. Matheny(Vanderbilt University), Shounak Chattopadhyay(University of California, Los Angeles), Clair Blacketer(Erasmus MC), Anna Ostropolets(Columbia University), Rohan Khera(Yale New Haven Hospital), Jin Zhou(University of California, Los Angeles), Thomas Falconer(Columbia University), Benjamin Viernes(University of Utah), Kenneth K. C. Man(University College London Hospitals NHS Foundation Trust), Scott L. DuVall(University of Utah), Nestoras Mathioudakis(Johns Hopkins University), Andrea Pistillo(Institut Universitari d'Investigació en Atenció Primària Jordi Gol), George Hripcsak(Columbia University Irving Medical Center), Lauren R. Richter(Columbia University Irving Medical Center), Akihiko Nishimura(Johns Hopkins University), Carlen Reyes(Institut Universitari d'Investigació en Atenció Primària Jordi Gol), Patrick Ryan(Johnson & Johnson (United States)), Talita Duarte‐Salles(Erasmus MC), Wallis C. Y. Lau(University College London Hospitals NHS Foundation Trust), Martijn J. Schuemie, Can Yin, Yuan Lu, Fan Bu(University of Michigan), Yi Chai(University of Hong Kong), Harlan M. Krumholz(Yale New Haven Hospital), Katherine Simon(VA Tennessee Valley Healthcare System), Feng Sun(Guangzhou University of Chinese Medicine), Sarah Seager(IQVIA (United Kingdom)), Evan Minty(University of Calgary)
Diabetes Care
June 4, 2025
Cited by 14


Related Papers